Skip to content

Ashland

US · ASH #2461 by market cap Listed 1970
72.40 -1.72 -2.32%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 16 in the most recent period (2026/Q3).
  • Total institutional ownership rose 1.5 percentage points.

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
116.55% +1.49pp
Institutions
430 +16
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund83.58%
Hedge Fund25.87%
Public Company3.59%
Private Company2.00%
Individual/Insider1.22%
Government Pension Fund1.00%
Insurance Company0.27%
Family Office/Trust0.19%

Top holders as of 2026-09-30

BlackRock 12.63% · 5.78M sh
Standard Investments LLC 9.88% · 4.53M sh
Omega Advisors, Inc. 6.37% · 2.92M sh
Dimensional Fund Advisors 5.74% · 2.63M sh
Franklin Resources 5.56% · 2.55M sh
Vanguard Portfolio Management, LLC 5.01% · 2.29M sh
MFS Investment Management 4.45% · 2.04M sh
Vanguard Capital Management, LLC 5.17% · 2.37M sh
Frontier Capital Management 4.37% · 2.00M sh
Ancora Advisors LLC 4.25% · 1.95M sh
State Street Global Advisors 4.20% · 1.92M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 45 buys · 4 sells

NameRoleStake
John Willis Former Senior VP, CFO & Principal Accounting Officer 0.59%
Guillermo Novo Chairperson & CEO 0.38%
Osama Musa Chief Technology Officer 0.08%
Susan Main Lead Independent Director 0.03%
Jerome Peribere Independent Director 0.02%
Alessandra Assis Senior VP and GM of Life Sciences & Intermediates 0.02%
Eileen Drury Senior VP & Chief HR Officer 0.02%
James Minicucci Senior VP & GM of Personal Care 0.02%
Robin Lampkin Senior Vice President 0.02%
Karl Bostaph Former Officer 0.02%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-29 Stephen Bishop Independent Director Other Derivative Acquisition +368 --
2026-09-29 Sanat Chattopadhyay Independent Director Other Derivative Acquisition +212 --
2026-09-20 Osama Musa Chief Technology Officer Derivative Exercise and Sale -3,647 $69.06
2026-09-20 Osama Musa Chief Technology Officer Derivative Exercise and Retained +6,771 $69.06
2026-09-14 Osama Musa Chief Technology Officer Other Derivative Acquisition +14,230 --
2026-08-10 Robin Lampkin Senior Vice President Derivative Exercise and Sale -526 $74.58
2026-08-10 Robin Lampkin Senior Vice President Derivative Exercise and Retained +1,280 $74.58
2026-07-28 Osama Musa Chief Technology Officer Derivative Exercise and Retained +1,267 $57.96
2026-07-26 Allen Spizzo Independent Director Other Derivative Acquisition +978 --
2026-07-26 Peter Thomas Independent Director Other Derivative Acquisition +978 --
2026-07-26 Peter Thomas Independent Director Initial Statement of Beneficial 0 --
2026-07-26 Alessandra Assis Senior VP and GM of Life Sciences & Intermediates Derivative Exercise and Sale -884 $66.38
2026-07-26 Alessandra Assis Senior VP and GM of Life Sciences & Intermediates Derivative Exercise and Retained +2,331 $66.38
2026-06-29 Stephen Bishop Independent Director Other Derivative Acquisition +379 --
2026-06-29 Sanat Chattopadhyay Independent Director Other Derivative Acquisition +218 --
2026-05-14 Bertrand Loy Independent Director Other Derivative Acquisition +1,741 --
2026-05-07 James Minicucci Senior VP & GM of Personal Care Derivative Exercise and Sale -1,346 $55.01
2026-05-07 James Minicucci Senior VP & GM of Personal Care Derivative Exercise and Retained +2,964 $55.01
2026-03-30 Stephen Bishop Independent Director Other Derivative Acquisition +450 --
2026-03-30 Sanat Chattopadhyay Independent Director Other Derivative Acquisition +258 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Ashland discussion 0 comments

Add a comment